Hanna GJ, ONeill A, Shin KY, Wong K, et al. Neoadjuvant and adjuvant nivolumab and lirilumab in patients with recurrent, resectable squamous cell carcinoma of the head and neck. Clin Cancer Res 2021 Oct 19. pii: 1078-0432.CCR-21-2635.
PMID: 34667025